Stock comparison
Mettler-Toledo International
Soleno Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
SLNO
Soleno Therapeutics
Market cap
$2.76B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | SLNO | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 57C | MTD |
| Benjamin Graham | 65B | 66D | SLNO |
| Philip Fisher | 63C | 69C | SLNO |
| Peter Lynch | 66B | 58C | MTD |
| Joel Greenblatt | 68B | 62C | MTD |
| Charlie Munger | 74B | 63D | MTD |
| Terry Smith | 70B | 66B | MTD |
Side-by-side metrics
| Metric | MTD | SLNO |
|---|---|---|
| Market cap | $22.29B | $2.76B |
| P/E (TTM) | 25.3x | 28.7x |
| EV/EBIT | 21.6x | 176.1x |
| ROIC (TTM) | 36.09% | 15.35% |
| Gross margin | 57.79% | 98.63% |
| Net margin | 21.4% | 33.7% |
| Revenue CAGR 5y | 2.01% | - |
| EPS CAGR 5y | 6.12% | - |
| Debt / Equity | - | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 0.0x+100%
- EV/EBIT21.6xvs 176.1x+88%
- Market cap$22.29Bvs $2.76B+88%
- ROIC (TTM)36.09%vs 15.35%+57%
SLNO leads on
- Gross margin98.63%vs 57.79%+41%
- Net margin33.7%vs 21.4%+37%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.